• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Bel Fuse Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    4/24/25 5:28:50 PM ET
    $BELFB
    Get the next $BELFB alert in real time by email
    belfb20250303_8k.htm
    false 0000729580 0000729580 2025-04-24 2025-04-24 0000729580 belfb:ClassACommonStockCustomMember 2025-04-24 2025-04-24 0000729580 belfb:ClassBCommonStockCustomMember 2025-04-24 2025-04-24
     
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    FORM 8-K
     
    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934
     
    Date of report (Date of earliest event reported): April 24, 2025
     
    BELFUSE INC /NJ
    BELFUSE INC /NJ
    BEL FUSE INC.
    (Exact Name of Registrant as Specified in its Charter)
     
    New Jersey
     
    0-11676
     
    22-1463699
    (State of incorporation)
     
    (Commission File Number)
     
    (I.R.S. Employer Identification No.)
     
     
    300 Executive Drive, Suite 300, West Orange, New Jersey
     
    07052
    (Address of principal executive offices)
     
    (Zip Code)
     
    Registrant's telephone number, including area code:  (201) 432-0463
     
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
     
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐          Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐          Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act  (17 CFR 240.14d-2(b))
     
    ☐          Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of Each Class
     
    Trading Symbol
     
    Name of Exchange on Which Registered
    Class A Common Stock ($0.10 par value)
     
    BELFA
     
    Nasdaq Global Select Market
    Class B Common Stock ($0.10 par value)
     
    BELFB
     
    Nasdaq Global Select Market
     
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    Item 2.02.  Results of Operations and Financial Condition.
     
    On April 24, 2025, Bel Fuse Inc. ("Bel" or the "Company") issued a press release regarding results for the three months ended March 31, 2025.  A copy of this press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.
     
    In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
     
     
    Item 9.01.   Financial Statements and Exhibits.
     
    (d) Exhibits
     
    99.1
    Press Release of Bel Fuse Inc. dated April 24, 2025, related to the financial results of the Company for the three months ended March 31, 2025, furnished hereto.
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
     

     
     
    SIGNATURE
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    Date: April 24, 2025
     BEL FUSE INC.
     
     (Registrant)
     
     
     
     
    By:  
     /s/Daniel Bernstein
     
    Daniel Bernstein
     
    President and Chief Executive Officer
     
     

     
     
    EXHIBIT INDEX
     
     
     
    Exhibit No.
     
     
    Description
     
     
             
     99.1
     
    Press Release of Bel Fuse Inc., dated April 24, 2025, related to the financial results of the Company for the three months ended March 31, 2025, furnished hereto.
     
     
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)    
     
     
    Get the next $BELFB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BELFB

    DatePrice TargetRatingAnalyst
    6/10/2025$88.00Outperform
    Robert W. Baird
    3/25/2025$115.00Buy
    Craig Hallum
    12/17/2024$105.00Outperform
    Oppenheimer
    9/5/2024$80.00Market Perform → Outperform
    Northland Capital
    5/2/2024$63.00Outperform → Market Perform
    Northland Capital
    1/11/2024$83.00Outperform
    Northland Capital
    2/28/2022$21.00 → $25.00Buy
    Needham
    More analyst ratings